Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 52, Issue 7, 2005, Pages 2069-2079

  Morgan, Philip E ^a   Sturgess, Allan D ^b   Davies, Michael J ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ANTICOAGULANT AGENT; ANTIMALARIAL AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHIONINE; MYELOPEROXIDASE; PHENYLALANINE; PLASMA PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; MALE; MULTIPLE ORGAN FAILURE; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RADIOIMMUNOASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; BLOOD PROTEINS; DNA; FEMALE; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE; PROTEIN BINDING; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX; SULFHYDRYL COMPOUNDS;

EID: 22344451993     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21130     Document Type: Article

References (55)

1. Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology (Oxford) 2002;41:1095-100.
2. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
3. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997;145:408-15.
4. Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003;24:595-602.
5. Waszczykowska E, Robak E, Wozniacka A, Narbutt J, Torzecka JD, Sysa-Jedrzejowska A. Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation. Mediators Inflamm 1999;8:93-100.
6. Lahita RG, Bradlow HL, Ginzler E, Pang S, New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987;30:241-8.
7. Kaplan MJ. Apoptosis in systemic lupus erythematosus. Clin Immunol 2004;112:210-8.
8. Alves JD, Ames PR. Atherosclerosis, oxidative stress and autoantibodies in systemic lupus erythematosus and primary antiphospholipid syndrome. Immunobiology 2003;207:23-8.
9. Lunec J, Herbert K, Blount S, Griffiths HR, Emery P. 8- hydroxydeoxyguanosine: a marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 1994;348:131-8.
10. Cooke MS, Mistry N, Wood C, Herbert KE, Lunec J. Immunogenicity of DNA damage by reactive oxygen species: implications for anti-DNA antibodies in lupus. Free Radic Biol Med 1997;22: 151-9.
11. Vaarala O. Antibodies to oxidised LDL. Lupus 2000;9:202-5.
12. Miesel R, Zuber M. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune diseases. Inflammation 1993;17:551-61.
13. Bae SC, Kim SJ, Sung MK. Impaired antioxidant status and decreased dietary intake of antioxidants in patients with systemic lupus erythematosus. Rheumatol Int 2002;22:238-43.
14. Comstock GW, Burke AE, Hoffman SC, Helzlsouer KJ, Bendich A, Masi AT, et al. Serum concentrations of α tocopherol, β carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1997;56:323-5.
15. Davies MJ. The oxidative environment and protein damage. Biochim Biophys Acta 2005;1703:93-109.
16. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997;324: 1-18.
17. Morgan PE, Dean RT, Davies MJ. Protective mechanisms against peptide and protein peroxides generated by singlet oxygen. Free Radic Biol Med 2004;36:484-96.
18. Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J 1997;11:526-34.
19. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadida R, et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 2003;375:581-92.
20. Davies MJ, Fu S, Wang H, Dean RT. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med 1999;27:1151-63.
21. Kettle AJ, Winterbourn CC. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep 1997;3:3-15.
22. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. J Am Med Assoc 2001;286:2136-42.
23. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
24. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
25. Ramsey-Goldman R, Isenberg DA. Systemic lupus erythematosus measures: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Measure (SLEDAI), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology-Damage Index (SLICC/ACR-DI; SDI). Arthritis Rheum 2003;49 Suppl 5:S225-33.
26. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994;233:380-5.
27. Simpson RJ. Complete amino acid analysis of proteins from a single hydrolysate. J Biol Chem 1976;251:1936-40.
28. Fu S, Wang H, Davies M, Dean R. Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine. J Biol Chem 2000;275:10851-8.
29. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997;272:20313-6.
30. Hawkins CL, Davies MJ. Generation and propagation of radical reactions on proteins [review]. Biochim Biophys Acta 2001;1504: 196-219.
31. Leung-Toung R, Li W, Tam TF, Karimian K. Thiol-dependent enzymes and their inhibitors: a review. Curr Med Chem 2002;9: 979-1002.
32. Stadtman ER. Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation. Arch Biochem Biophys 2004;423:2-5.
33. Hoshi T, Heinemann SH. Regulation of cell function by methionine oxidation and reduction. J Physiol 2001;531:1-11.
34. Chao CC, Ma YS, Stadtman ER. Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. Proc Natl Acad Sci U S A 1997;94:2969-74.
35. Potgieter HC, Ubbink JB, Bissbort S, Bester MJ, Spies JH, Vermaak WJ. Spontaneous oxidation of methionine: effect on the quantitation of plasma methionine levels. Anal Biochem 1997;248: 86-93.
36. Quinlan GJ, Evans TW, Gutteridge JM. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic Res 1994;20:289-98.
37. Kadota K, Yui Y, Hattori R, Murohara Y, Kawai C. Decreased sulfhydryl groups of serum albumin in coronary artery disease. Jpn Circ J 1991;55:937-41.
38. Lorber A, Pearson CM, Meredith WL, Gantz-Mandell LE. Serum sulfhydryl determinations and significance in connective tissue diseases. Ann Intern Med 1964;61:423-34.
39. Lorber A, Bovy RA, Chang CC. Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations. Metabolism 1971;20:446-55.
40. Kleinman WA, Richie JP. Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol 2000;60: 19-29.
41. Svardal AM, Mansoor MA, Ueland PM. Determination of reduced, oxidized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal Biochem 1990;184:338-46.
42. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of disease-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563-74.
43. Winterbourn CC, Chan T, Buss IH, Inder TE, Mogridge N, Darlow BA. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effects of selenium supplementation. Pediatr Res 2000;48:84-90.
44. Buss IH, Darlow BA, Winterbourn CC. Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants. Pediatr Res 2000;47: 640-5.
45. Shacter E, Williams JA, Lim M, Levine RL. Differential susceptibility of plasma proteins to oxidative modification: examination by western blot immunoassay. Free Radic Biol Med 1994;17: 429-37.
46. Minota S, Horie S, Yamada A, Iwamoto M, Yoshio T, Mimori A, et al. Circulating myeloperoxidase and anti-myeloperoxidase antibody in patients with vasculitis. Scand J Rheumatol 1999;28:94-9.
47. Headlam HA, Davies MJ. β-scission of side-chain alkoxyl radicals on peptides and proteins results in the loss of side-chains as aldehydes and ketones. Free Radic Biol Med 2002;32:1171-84.
48. Headlam HA, Davies MJ. Markers of protein oxidation: different oxidants give rise to variable yields of bound and released carbonyl products. Free Radic Biol Med 2004;36:1175-84.
49. Gilkeson G, Cannon C, Dates J, Reilly C, Goldman D, Petri M. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999;26:318-24.
50. Oates JC, Christensen EF, Reilly CM, Self SE, Gilkeson GS. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians 1999;111:611-21.
51. -) in aqueous solution. J Phys Chem Ref Data 1988;17:513-886.
52. Lo TW, Westwood ME, McLellan AC, Selwood T, Thornalley PJ. Binding and modification of proteins by methylglyoxal under physiological conditions: a kinetic and mechanistic study with N α-acetylarginine, N α-acetylcysteine, and N α-acetyllysine, and bovine serum albumin. J Biol Chem 1994;269:32299-305.
53. D'Cruz D. Testing for autoimmunity in humans. Toxicol Lett 2002;127:93-100.
54. Ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term, prospective study. Arthritis Rheum 1990;33:634-43.
55. Jones IR, Owens DR, Williams S, Ryder RE, Birtwell AJ, Jones MK, et al. Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care 1983;6:501-3.